Alvotech (NASDAQ:ALVOW – Get Free Report) traded down 20.3% during trading on Wednesday . The stock traded as low as $0.4734 and last traded at $0.51. 200 shares traded hands during trading, a decline of 91% from the average session volume of 2,300 shares. The stock had previously closed at $0.64.
Alvotech Stock Down 20.3%
The stock’s fifty day moving average price is $0.72 and its 200-day moving average price is $1.20.
About Alvotech
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Featured Stories
- Five stocks we like better than Alvotech
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
- If You Keep Cash In A U.S. Bank Account… Read This NOW
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
